Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy-Reference-Cited by-同舟云学术

Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

Published:2016-06-02 Issue:22 Volume:127 Page:2742-2750
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Wang Wei¹,Cortes Jorge E.²,Tang Guilin¹,Khoury Joseph D.¹,Wang Sa¹,Bueso-Ramos Carlos E.¹,DiGiuseppe Joseph A.³,Chen Zi¹,Kantarjian Hagop M.²,Medeiros L. Jeffrey¹,Hu Shimin¹

Affiliation:

1. Department of Hematopathology and

2. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; and

3. Department of Pathology, Hartford Hospital, Hartford, CT

Abstract

Key Points Based on their impact on treatment and survival, ACAs in CML were stratified into good and poor prognostic groups. ACAs in the good prognostic group showed no adverse impact on survival when they emerged from chronic phase or at the initial CML diagnosis.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/127/22/2742/1393211/2742.pdf

Reference31 articles.

1. Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progression.;Marktel;Haematologica,2003

2. Revised international prognostic scoring system for myelodysplastic syndromes.;Greenberg;Blood,2012

3. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.;Grimwade;Blood,2010

4. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.;Baccarani;Blood,2013

5. Chronic myeloid leukemia.;Fioretos,2009

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring;American Journal of Hematology;2024-08-02

2. Impact of additional cytogenetic aberrations at diagnosis on prognosis of adults patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: a retrospective analysis;Annals of Hematology;2024-07-04

3. Cytogenetics and genomics in CML and other myeloproliferative neoplasms;Best Practice & Research Clinical Haematology;2024-06

4. Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia;International Journal of Hematology;2024-05-15

5. Impact of Additional Cytogenetic Aberrations at Diagnosis on Prognosis of Adults Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation：A Retrospective Analysis;2024-04-25